 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
April 23, 2020
Silverback Therapeutics
Dr. Laura Shawver is the new president and CEO of Silverback Therapeutics, a Seattle-based private biopharmaceutical company. Shawver has over 25 years of experience as a scientist, biotech leader and patient advocate. She was CEO and director of Synthorx from 2017 until its acquisition by Sanofi in January. She also was CEO and director of Cleave Biosciences, entrepreneur-in-residence for 5AM Ventures, CEO and director at Phenomix and president of Sugen. At Silverback, she also is on the board. Silverback is developing ways to eradicate solid tumors.